Vol 2022, No 12 (2022)

Table of Contents

Licensing

Kite Enters into License Agreement with Arcellx for CART-ddBCMA in Multiple Myeloma Abstract pdf html
Ayush Saxena
Novartis Signs License Agreement with MorphoSys to Develop and Commercialise Preclinical Inhibitors for Cancer Abstract pdf html
Ashish Tripathi
AbbVie Forms Auto-Immunology Partnership with HotSpot Therapeutics for US$335M Abstract pdf html
Swati Sharan

Mergers & Acquisitions

AstraZeneca Bolsters Pipeline with Neogene Therapeutics and C4X Discovery Deals Abstract pdf html
Lucy Haggerty & Amit Kaushik
Amgen to Acquire Horizon Therapeutics for US$28.3 B Abstract pdf html
Lucy Haggerty


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.